Evaluation of oral herpes simplex virus shedding among solid organ transplant recipients: A pilot study

Documents similaires

• The devil is in the details: Nuances of pre‐emptive therapy for cytomegalovirus disease prevention in high‐risk seropositive donors liver transplant recipients
  par: Madeleine R. Heldman, et autres
  Publié: (2024)
• A practical guide to real‐world implementation of pre‐emptive therapy for Cytomegalovirus disease prevention in high‐risk seronegative liver transplant recipients with seropositive donors
  par: Madeleine R. Heldman, et autres
  Publié: (2024)
• Pediatric solid organ transplant recipients positive for severe acute respiratory syndrome coronavirus 2 pre‐transplant
  par: Taylor Heald‐Sargent, et autres
  Publié: (2024)
• Malignancy following solid organ transplantation: Current techniques for determination of donor versus recipient origin
  par: Rebecca Rojansky, et autres
  Publié: (2024)
• Advancing cytomegalovirus prevention in solid organ transplant recipients: The promise of cell‐mediated immune assays
  par: Vivek B. Beechar, et autres
  Publié: (2024)